Tamada R, Hiramoto Y, Abe Y, Nouzuka T, Okamura T, Masuda H, Kano T, Kumashiro R, Inokuchi K
Jpn J Surg. 1982;12(6):429-33. doi: 10.1007/BF02469833.
In attempts to predict the recurrence of gastric cancer, postoperative changes in serum carcinoembryonic antigen (CEA) levels are monitored in our clinic by radioimmunoassay (Dainabot, Japan). Recurrences are suspected when serum CEA levels are 4 ng/ml, in the postoperative period. Out of 34 patients in whom there were increases in serum CEA, 18 were confirmed to have a recurrence and 15 of these 18 patients were assessed accurately by serial postoperative levels of CEA, two patients died of a recurrence after elevation of serum CEA levels. Thus, recurrence was predicted in 17 out of 34 patients (50 per cent) and in 12 out of 17 patients there was a metastasis to the liver. In 14 out of 34 patients there are no signs of recurrence 9 to 25 months after serum CEA elevations.
为了预测胃癌的复发情况，我们诊所通过放射免疫分析法（日本戴拿保公司产品）监测血清癌胚抗原（CEA）水平的术后变化。术后血清CEA水平≥4 ng/ml时怀疑有复发。在34例血清CEA升高的患者中，18例被证实复发，其中15例通过术后连续的CEA水平得到准确评估，2例患者在血清CEA水平升高后死于复发。因此，34例患者中有17例（50%）预测有复发，其中12例有肝转移。34例患者中有14例在血清CEA升高后9至25个月无复发迹象。
